Celera CORP - FORM 10-K - EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - March 17, 2011

Attached files

file	filename
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A) - Celera CORP	dex312.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Celera CORP	dex231.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - Celera CORP	dex322.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 - Celera CORP	dex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A) - Celera CORP	dex311.htm
EX-10.47 - EMPLOYMENT OFFER LETTER - Celera CORP	dex1047.htm
10-K - FORM 10-K - Celera CORP	d10k.htm

Exhibit 21.1

Celera Corporation Subsidiaries


Name		State of Incorporation or Organization
Axys Pharmaceuticals, Inc.			Delaware
Axys 468 Littlefield LLC			California
Berkeley HeartLab, Inc.			California
Celera Diagnostics, LLC			Delaware
Foster City Holdings, LLC			Delaware	(1)
GenScope, Inc.			Delaware	(1)
Paracel, Inc.			California	(1)
Paracel Government Systems, Inc.			Delaware	(1)
Rockville Holdings, LLC			Delaware	(1)

(1)	This entity is considered dormant and/or has no material operations/assets.